Cargando…

COVID-19 related callback in blood donors; Outcomes in blood donors and patients

Call back as a procedure to report post donation symptoms or illness by donors has been established since 2009 in Iranian Blood Transfusion Organization (IBTO). During the first phase of COVID-19 outbreak, all blood donors were requested to report any respiratory infection symptoms after donation. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Balagholi, Sahar, Maghsudlu, Mahtab, Amini-Kafiabad, Sedigheh, Nazemi, Amir Masoud, Sotoudeh Anvari, Maryam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019242/
https://www.ncbi.nlm.nih.gov/pubmed/33879420
http://dx.doi.org/10.1016/j.transci.2021.103129
_version_ 1783674339027058688
author Balagholi, Sahar
Maghsudlu, Mahtab
Amini-Kafiabad, Sedigheh
Nazemi, Amir Masoud
Sotoudeh Anvari, Maryam
author_facet Balagholi, Sahar
Maghsudlu, Mahtab
Amini-Kafiabad, Sedigheh
Nazemi, Amir Masoud
Sotoudeh Anvari, Maryam
author_sort Balagholi, Sahar
collection PubMed
description Call back as a procedure to report post donation symptoms or illness by donors has been established since 2009 in Iranian Blood Transfusion Organization (IBTO). During the first phase of COVID-19 outbreak, all blood donors were requested to report any respiratory infection symptoms after donation. The study investigated the callback data of COVID-19 in Tehran Blood Center during the first 3 months of the outbreak in Iran. The purpose of this study was to estimate the frequency of post donation COVID-19 related call back reports and determine its implications for blood donors and patients. A telephone interview was conducted with donors who had reported COVID-19 symptoms. Some questions were asked to evaluate donor′s health at the time of blood donation. The donors categorized into three groups: laboratory-confirmed, suspected, and COVID-19 irrelevant based on their answers. In cases that the blood component obtained from a laboratory-confirmed donor had been released, the hospital was notified and asked to follow up the recipient for COVID-19. The results showed 30 donors (0.08 %) had callback related to COVID-19 and 76.63 % of the obtained component was disposed. The results also showed that only one donor had a laboratory-confirmed result with the RBC unit processed from her whole blood released for transfusion. The RBC unit recipient did not show any signs or symptoms of infection during a 46-day follow-up. Concluded that callback system was effective to remove most of the components obtained from the donors who reported to be COVID-19 suspected or confirmed. Moreover, the result did not support virus transmission through blood transfusion.
format Online
Article
Text
id pubmed-8019242
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-80192422021-04-06 COVID-19 related callback in blood donors; Outcomes in blood donors and patients Balagholi, Sahar Maghsudlu, Mahtab Amini-Kafiabad, Sedigheh Nazemi, Amir Masoud Sotoudeh Anvari, Maryam Transfus Apher Sci Article Call back as a procedure to report post donation symptoms or illness by donors has been established since 2009 in Iranian Blood Transfusion Organization (IBTO). During the first phase of COVID-19 outbreak, all blood donors were requested to report any respiratory infection symptoms after donation. The study investigated the callback data of COVID-19 in Tehran Blood Center during the first 3 months of the outbreak in Iran. The purpose of this study was to estimate the frequency of post donation COVID-19 related call back reports and determine its implications for blood donors and patients. A telephone interview was conducted with donors who had reported COVID-19 symptoms. Some questions were asked to evaluate donor′s health at the time of blood donation. The donors categorized into three groups: laboratory-confirmed, suspected, and COVID-19 irrelevant based on their answers. In cases that the blood component obtained from a laboratory-confirmed donor had been released, the hospital was notified and asked to follow up the recipient for COVID-19. The results showed 30 donors (0.08 %) had callback related to COVID-19 and 76.63 % of the obtained component was disposed. The results also showed that only one donor had a laboratory-confirmed result with the RBC unit processed from her whole blood released for transfusion. The RBC unit recipient did not show any signs or symptoms of infection during a 46-day follow-up. Concluded that callback system was effective to remove most of the components obtained from the donors who reported to be COVID-19 suspected or confirmed. Moreover, the result did not support virus transmission through blood transfusion. Published by Elsevier Ltd. 2021-08 2021-04-03 /pmc/articles/PMC8019242/ /pubmed/33879420 http://dx.doi.org/10.1016/j.transci.2021.103129 Text en © 2021 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Balagholi, Sahar
Maghsudlu, Mahtab
Amini-Kafiabad, Sedigheh
Nazemi, Amir Masoud
Sotoudeh Anvari, Maryam
COVID-19 related callback in blood donors; Outcomes in blood donors and patients
title COVID-19 related callback in blood donors; Outcomes in blood donors and patients
title_full COVID-19 related callback in blood donors; Outcomes in blood donors and patients
title_fullStr COVID-19 related callback in blood donors; Outcomes in blood donors and patients
title_full_unstemmed COVID-19 related callback in blood donors; Outcomes in blood donors and patients
title_short COVID-19 related callback in blood donors; Outcomes in blood donors and patients
title_sort covid-19 related callback in blood donors; outcomes in blood donors and patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019242/
https://www.ncbi.nlm.nih.gov/pubmed/33879420
http://dx.doi.org/10.1016/j.transci.2021.103129
work_keys_str_mv AT balagholisahar covid19relatedcallbackinblooddonorsoutcomesinblooddonorsandpatients
AT maghsudlumahtab covid19relatedcallbackinblooddonorsoutcomesinblooddonorsandpatients
AT aminikafiabadsedigheh covid19relatedcallbackinblooddonorsoutcomesinblooddonorsandpatients
AT nazemiamirmasoud covid19relatedcallbackinblooddonorsoutcomesinblooddonorsandpatients
AT sotoudehanvarimaryam covid19relatedcallbackinblooddonorsoutcomesinblooddonorsandpatients